Terms: = Colorectal cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
759 results:
1. Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment.
Lu W; Wang Q; Liu L; Luo W
Sci Rep; 2024 May; 14(1):10883. PubMed ID: 38740818
[TBL] [Abstract] [Full Text] [Related]
2. MYC and NCAPG2 as molecular targets of colorectal cancer and gastric cancer in nursing.
Mi X; Shan H; Kang C; Zhang J; Hou S; Gao Y; Hao L; Gao X; Gao Q; Chi X; Zhang Q
Medicine (Baltimore); 2024 May; 103(18):e38029. PubMed ID: 38701261
[TBL] [Abstract] [Full Text] [Related]
3. Genetic and microbial determinants of azoxymethane-induced colorectal tumor susceptibility in Collaborative Cross mice and their implication in human cancer.
Li D; Zhong C; Yang M; He L; Chang H; Zhu N; Celniker SE; Threadgill DW; Snijders AM; Mao JH; Yuan Y
Gut Microbes; 2024; 16(1):2341647. PubMed ID: 38659246
[TBL] [Abstract] [Full Text] [Related]
4. Conditional survival analysis and real-time prognosis prediction in stage III T3-T4 colon cancer patients after surgical resection: a SEER database analysis.
Zeng H; Xue X; Chen D; Zheng B; Liang B; Que Z; Xu D; Wang X; Lin S
Int J Colorectal Dis; 2024 Apr; 39(1):54. PubMed ID: 38639915
[TBL] [Abstract] [Full Text] [Related]
5. Mining and exploration of rehabilitation nursing targets for colorectal cancer.
Li R; He J; Ni Z; Zhang J; Chi X; Kang C; Li Z; Li X
Aging (Albany NY); 2024 Apr; 16(8):7022-7042. PubMed ID: 38637125
[TBL] [Abstract] [Full Text] [Related]
6. High-Throughput Metabolic Pattern Screening Strategy for Early colorectal and Gastric cancers Based on Covalent Organic Frameworks-Assisted Laser Desorption/Ionization Mass Spectrometry.
Yang C; Yu H; Li W; Lin H; Wu H; Deng C
Anal Chem; 2024 Apr; 96(16):6264-6274. PubMed ID: 38600676
[TBL] [Abstract] [Full Text] [Related]
7. Identification and validation of regulatory T cell-associated gene signatures to predict colon adenocarcinoma prognosis.
Zhao X; Li X; Miao Z
Int Immunopharmacol; 2024 May; 132():112034. PubMed ID: 38588631
[TBL] [Abstract] [Full Text] [Related]
8. A new clinical model for predicting lymph node metastasis in T1 colorectal cancer.
Wang K; He H; Lin Y; Zhang Y; Chen J; Hu J; He X
Int J Colorectal Dis; 2024 Apr; 39(1):46. PubMed ID: 38565736
[TBL] [Abstract] [Full Text] [Related]
9. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
Rao C; Tong J; Yang Y
Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
[TBL] [Abstract] [Full Text] [Related]
10. Identification of Genomic Signatures for colorectal cancer Survival Using Exploratory Data Mining.
Hummel JJ; Liu D; Tallon E; Snyder J; Warren W; Shyu CR; Mitchem J; Cortese R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542194
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic colorectal cancer.
Gherman A; Bolundut D; Ecea R; Balacescu L; Curcean S; Dina C; Balacescu O; Cainap C
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541123
[TBL] [Abstract] [Full Text] [Related]
12. Exploration of signature based on T cell-related genes in stomach adenocarcinoma by analysis of single cell sequencing data.
Wang H; An N; Pei A; Sun Y; Li S; Chen S; Zhang N
Aging (Albany NY); 2024 Mar; 16(7):6035-6053. PubMed ID: 38536020
[TBL] [Abstract] [Full Text] [Related]
13. Extranodal Extension at Pretreatment MRI and the Prognostic Value for Patients with Rectal cancer.
Li QY; Yang D; Guan Z; Yan XY; Li XT; Sun RJ; Lu QY; Zhang XY; Sun YS
Radiology; 2024 Mar; 310(3):e232605. PubMed ID: 38530176
[TBL] [Abstract] [Full Text] [Related]
14. Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T-cell costimulator as a crucial immune checkpoint molecule.
Chu J; Wu Y; Qu Z; Zhuang J; Liu J; Han S; Wu W; Han S
Cancer Med; 2024 Mar; 13(6):e7097. PubMed ID: 38506253
[TBL] [Abstract] [Full Text] [Related]
15. HIF-1α Mediates Immunosuppression and Chemoresistance in colorectal cancer by Inhibiting CXCL9, -10 and -11.
Su Y; Liu J; Tian Y; Dong H; Shi M; Zhang J; Li W; Huang Q; Xiang N; Wang C; Liu J; He L; Hu L; Haberman AM; Liu H; Yang X
Biomed Pharmacother; 2024 Apr; 173():116427. PubMed ID: 38484558
[TBL] [Abstract] [Full Text] [Related]
16. Single-cell RNA profiling reveals classification and characteristics of mononuclear phagocytes in colorectal cancer.
Ji T; Fu H; Wang L; Chen J; Tian S; Wang G; Wang L; Wang Z
PLoS Genet; 2024 Feb; 20(2):e1011176. PubMed ID: 38408082
[TBL] [Abstract] [Full Text] [Related]
17. Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer.
Chen Y; Wang B; Zhao Y; Shao X; Wang M; Ma F; Yang L; Nie M; Jin P; Yao K; Song H; Lou S; Wang H; Yang T; Tian Y; Han P; Hu Z
Nat Commun; 2024 Feb; 15(1):1657. PubMed ID: 38395893
[TBL] [Abstract] [Full Text] [Related]
18. Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis.
Li S; Li T; Shi YQ; Xu BJ; Deng YY; Sun XG
Cancer Biomark; 2024; 40(1):27-45. PubMed ID: 38393891
[TBL] [Abstract] [Full Text] [Related]
19. GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines.
Nummela P; Zafar S; Veikkolainen E; Ukkola I; Cinella V; Ayo A; Asghar MY; Välimäki N; Törnquist K; Karhu A; Laakkonen P; Aaltonen LA; Ristimäki A
Int J Cancer; 2024 Jun; 154(11):1987-1998. PubMed ID: 38319157
[TBL] [Abstract] [Full Text] [Related]
20. Development and verification of a combined immune- and cancer-associated fibroblast related prognostic signature for colon adenocarcinoma.
Wei J; Ge X; Qian Y; Jiang K; Chen X; Lu W; Yang H; Fu D; Fang Y; Zhou X; Xiao Q; Tang Y; Ding K
Front Immunol; 2024; 15():1291938. PubMed ID: 38312843
[TBL] [Abstract] [Full Text] [Related]
[Next]
